Valbiotis SA (FR:ALVAL) has released an update.
Valbiotis has partnered with Asetys to enhance access to natural health solutions, meeting a growing demand for dietary supplements among French consumers. This collaboration will involve educational workshops and reimbursement for Valbiotis products, aiming to promote a proactive approach to health and wellness. Both companies plan to leverage their expertise to democratize health products and support partner therapists and insured members.
For further insights into FR:ALVAL stock, check out TipRanks’ Stock Analysis page.